Drugs / Tdap
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03313050 Comparator | Oct 2017 → May 2019 | pneumococcal infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tdap | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03313050 ↗ |
| Modality | Vaccine | “licensed tetanus, diphtheria, and acellular pertussis vaccine” PMID 33661716 ↗ Mar 2021 |